UNASSIGNED: A 38-year-old woman presented to our hospital for abdominal pain that persisted for 3 months. She was diagnosed as Barcelona Clinic Liver Cancer(BCLC) stage A, with a Cancer of the Liver Italian Program (CLIP) score of 3, American Joint Committee on Cancer (AJCC) Tumor-Node-Metastasis (TNM) staging systems stage IB. She refused surgical resection and trans-arterial chemoembolization and accepted a non-invasive systematic treatment strategy involving immunotherapy, anti-angiogenic therapy, and radiotherapy. Her tumor burden decreased, and she experienced partial response before radiotherapy. Following radiotherapy, she experienced a complete clinical response and has been alive for more than 36 months after her initial presentation. She is currently alive.
UNASSIGNED: A non-invasive systematic treatment strategy is a potential radical treatment option for patients with massive HCC.
■一名38岁的妇女因腹痛持续3个月来我院就诊。她被诊断为巴塞罗那诊所肝癌(BCLC)A期,意大利肝癌项目(CLIP)得分为3分,美国癌症联合委员会(AJCC)肿瘤淋巴结转移(TNM)分期系统IB期。她拒绝手术切除和经动脉化疗栓塞,并接受了包括免疫治疗的非侵入性系统治疗策略。抗血管生成治疗,和放射治疗。她的肿瘤负担减轻了,放疗前她有部分反应.放疗后,她经历了完全的临床反应,并且在初次就诊后已经存活了36个月以上。她目前还活着。
■非侵入性系统治疗策略是巨大HCC患者的潜在根治性治疗选择。